Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Suzetrigine by Vertex Pharmaceuticals for Diabetic Peripheral Neuropathy: Likelihood of Approval
Suzetrigine is under clinical development by Vertex Pharmaceuticals and currently in Phase III for Diabetic Peripheral Neuropathy. According to GlobalData,...
Suzetrigine by Vertex Pharmaceuticals for Radiculopathy: Likelihood of Approval
Suzetrigine is under clinical development by Vertex Pharmaceuticals and currently in Phase II for Radiculopathy. According to GlobalData, Phase II...
Suzetrigine by Vertex Pharmaceuticals for Post-Operative Pain: Likelihood of Approval
Suzetrigine is under clinical development by Vertex Pharmaceuticals and currently in Pre-Registration for Post-Operative Pain. According to GlobalData, Pre-Registration drugs...
Vanzacaftor calcium + deutivacaftor + tezacaftor by Vertex Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
Vanzacaftor calcium + deutivacaftor + tezacaftor is under clinical development by Vertex Pharmaceuticals and currently in Pre-Registration for Cystic Fibrosis....
VX-407 by Vertex Pharmaceuticals for Polycystic Kidney Disease: Likelihood of Approval
VX-407 is under clinical development by Vertex Pharmaceuticals and currently in Phase I for Polycystic Kidney Disease. According to GlobalData,...
VX-973 by Vertex Pharmaceuticals for Pain: Likelihood of Approval
VX-973 is under clinical development by Vertex Pharmaceuticals and currently in Phase I for Pain. According to GlobalData, Phase I...
VX-118 by Vertex Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
VX-118 is under clinical development by Vertex Pharmaceuticals and currently in Phase I for Cystic Fibrosis. According to GlobalData, Phase...
VXc-522 by Vertex Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
VXc-522 is under clinical development by Vertex Pharmaceuticals and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...
VC-01 by Vertex Pharmaceuticals for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
VC-01 is under clinical development by Vertex Pharmaceuticals and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes). According...
VX-993 by Vertex Pharmaceuticals for Pain: Likelihood of Approval
VX-993 is under clinical development by Vertex Pharmaceuticals and currently in Phase I for Pain. According to GlobalData, Phase I...
Risk adjusted net present value: What is the current valuation of Vertex Pharmaceuticals's Inaxaplin?
Inaxaplin is a small molecule commercialized by Vertex Pharmaceuticals, with a leading Phase III program in Focal Segmental Glomerulosclerosis (FSGS)....
VX-548 by Vertex Pharmaceuticals for Peripheral Neuropathic Pain: Likelihood of Approval
VX-548 is under clinical development by Vertex Pharmaceuticals and currently in Phase II for Peripheral Neuropathic Pain. According to GlobalData,...